Inozyme Pharma’s Big Leap: Why INZY Is Surging on BioMarin’s Acquisition News
Alright, folks, strap in because the market’s throwing us a curveball today, and Inozyme Pharma (NASDAQ: INZY) is stealing the spotlight! As of this writing, INZY is up a sizzling 5.19%, and the catalyst? A blockbuster acquisition deal with BioMarin Pharmaceutical...